Corosolic acid(4547-24-4)

Clinical application and efficacy Corosonic acid, as a new plant medicine for the prevention and treatment of obesity and type II diabetes, and as a functional natural health food pharmaceutical raw material, has become a popular product in the market. At present, the natural product has been marketed as a nutritional supplement in the United States, and the phase III clinical trial for the treatment of diabetes has been carried out at the same time. It will pass the FDA certification in the near future. Compared with insulin injection, it has obvious oral effect, less toxic and side effects, convenient use and other advantages in the treatment of diabetes, and its effect is equivalent to that of insulin injection. The content of the family Chemicalbook rosolic acid in plants is generally very low. Even the Lagerstroemia speciosa with a high content of rosolic acid, in its concentrated extract extracted by hot water, the content of rosolic acid is only about 0.01%; In the alcohol concentrated extract of Barnabar leaves, the content of corosolic acid is only about 1%. After years of research, Microherb has successfully separated 98% high-purity corosonic acid by using advanced chromatographic separation technology, which is used for experimental and clinical studies on the efficacy and toxicology of the prevention and treatment of obesity and type II diabetes.